The mRNA vaccines help protect from COVID-19 severity, however multiple sclerosis (MS) disease modifying therapies (DMTs) might affect the development of humoral and T-cell specific response to vaccination.
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine / Dominelli, F., Zingaropoli, M.A., Tartaglia, M., Tortellini, E., Guardiani, M., Perri, V., Pasculli, P., Ciccone, F., Malimpensa, L., Baione, V., Napoli, A., Gaeta, A., Lichtner, M., Conte, A., Mastroianni, C.M., Ciardi, M.R.. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 13:(2022), p. 1050183. [10.3389/fimmu.2022.1050183]
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
Dominelli, Federica;Zingaropoli, Maria Antonella
;Tartaglia, Matteo;Tortellini, Eeva;Guardiani, Mariasilvia;Perri, Valentina;Pasculli, Patrizia;Ciccone, Federica;Malimpensa, Leonardo;Baione, Viola;Napoli, Anna;Gaeta, Aurelia;Lichtner, Miriam;Conte, Antonella;Mastroianni, Claudio Maria;Ciardi, Maria Rosa
2022
Abstract
The mRNA vaccines help protect from COVID-19 severity, however multiple sclerosis (MS) disease modifying therapies (DMTs) might affect the development of humoral and T-cell specific response to vaccination.| File | Dimensione | Formato | |
|---|---|---|---|
|
fimmu-13-1050183.pdf
accesso aperto
Note: Dominelli_Multiple sclerosis-disease_2022
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.9 MB
Formato
Adobe PDF
|
1.9 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
